Macrogenics (MGNX) Reports In-Line Q4 EPS

Macrogenics (NASDAQ: MGNX) reported Q4 EPS of ($0.15), in-line with the analyst estimate of ($0.15). Revenue for the quarter came in at $58.8 million versus the consensus estimate of $34.13 million.

For earnings history and earnings-related data on Macrogenics (MGNX) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Goldman reinstates Estee Lauder rating, sees turnaround driving growth and margins
• Primoris cuts 2026 outlook on renewables cost overruns, COO exits